TN2013000172A1 - Formulations comprising polyethylene glycol - Google Patents

Formulations comprising polyethylene glycol

Info

Publication number
TN2013000172A1
TN2013000172A1 TNP2013000172A TN2013000172A TN2013000172A1 TN 2013000172 A1 TN2013000172 A1 TN 2013000172A1 TN P2013000172 A TNP2013000172 A TN P2013000172A TN 2013000172 A TN2013000172 A TN 2013000172A TN 2013000172 A1 TN2013000172 A1 TN 2013000172A1
Authority
TN
Tunisia
Prior art keywords
polyethylene glycol
solid
formulations
formulation
suckable
Prior art date
Application number
TNP2013000172A
Other languages
English (en)
Inventor
Peter Stein
Ian Cox
Leighton Jones
Samuel Smith
Jorg Plessl
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2011/001560 external-priority patent/WO2012059724A1/fr
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of TN2013000172A1 publication Critical patent/TN2013000172A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TNP2013000172A 2011-11-04 2013-04-22 Formulations comprising polyethylene glycol TN2013000172A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2011/001560 WO2012059724A1 (fr) 2010-11-04 2011-11-04 Formulations comportant du polyéthylène glycol

Publications (1)

Publication Number Publication Date
TN2013000172A1 true TN2013000172A1 (en) 2014-11-10

Family

ID=54360609

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000172A TN2013000172A1 (en) 2011-11-04 2013-04-22 Formulations comprising polyethylene glycol

Country Status (1)

Country Link
TN (1) TN2013000172A1 (fr)

Similar Documents

Publication Publication Date Title
MY164204A (en) Formulations comprising polyethylene glycol
HN2011003011A (es) Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas
CA2865972C (fr) Poudres seches pouvant etre inhalees
MX2013001677A (es) Formulaciones estables de linaclotida.
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
MY161595A (en) Oral care compositions
BR112013026363A2 (pt) nanossuspensões de fármaco criodessecadas
WO2011110939A3 (fr) Compositions pharmaceutiques de benzhydrylpipérazines substituées
HN2006009000A (es) Formas farmaceuticas con propiedades farmacocineticas mejoradas
CL2012001836A1 (es) Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros.
WO2012098562A3 (fr) Compositions liquides pour administration par voie orale de sels de lanthane
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
BR112012019997A2 (pt) composições de cuidado oral
TN2015000135A1 (en) Modified release formulations for oprozomib
WO2011002422A3 (fr) Formulation pharmaceutique améliorant la solubilité
WO2011142731A3 (fr) Formulations comprenant une céphalosporine et un acide clavulanique de troisième génération
WO2012064304A3 (fr) Combinaisions comprenant du montelukast
WO2011139249A3 (fr) Composition pharmaceutique renfermant du cefdinir
TR201902755T4 (tr) Depolama kararliliğina sahi̇p li̇yofi̇li̇ze tri̇pepti̇t formülasyonlari.
PH12015502717A1 (en) Anti-fibrogenic compounds, methods and uses thereof
IN2014MN01382A (fr)
TN2013000172A1 (en) Formulations comprising polyethylene glycol
WO2011039675A3 (fr) Formes posologiques thérapeutiques transdermiques de latrepirdine
SG10201501606VA (en) Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders
UA97076C2 (ru) Мазь противовоспалительная на основе сульфаниламида